Search
+
    Invest with Confidence. Lead with Insights.
    • Drench in the knowledge with exclusive insights, ePaper & smart market tools with ETPrime.

    Stock Radar: This pharma stock sees mild consolidation after 130% rally in 1 year; time to buy the dip?

    Synopsis

    The pharma stock is a part of the S&P BSE Smallcap index. It saw an uptrend, rising from Rs 393 as of June 9, 2023, to Rs 901 recorded on June 10, 2024. It has, however, undergone mild consolidation of approximately 100 points since April on the daily chart. The stock is in recovery mode with chances of momentum to continue are moderate. Short-term traders can look to accumulate the stock on dips.

    Strides Pharma Science has witnessed a breakout from a range on the daily charts, which has opened room for it to hit fresh 52-week high in June. The chart pattern suggests that the rally may not be over yet.Short-term traders can look to buy the stock on dips for a possible target above 1,000 level in 3-4 weeks, suggested experts.The pharma stock, also part of the S&P BSE Smallcap index, rose from Rs 393 as of June 9, 2023, to Rs 901 recorded
    • FONT SIZE
    • SAVE
    • PRINT
    • COMMENT
    ET

    Uh-oh! This is an exclusive story available for selected readers only.

    Worry not. You’re just a step away.

    Why ?

    • Exclusive Economic Times Stories, Editorials & Expert opinion across 20+ sectors

    • Stock analysis. Market Research. Industry Trends on 4000+ Stocks

    • Clean experience with
      Minimal Ads
    • Comment & Engage with ET Prime community
    • Exclusive invites to Virtual Events with Industry Leaders
    • A trusted team of Journalists & Analysts who can best filter signal from noise
    • ​Get 1 Year Complimentary Subscription of TOI+ worth Rs.799/-​

    The Economic Times